These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 32144424)
41. Impact of FDA Actions, DTCA, and Public Information on the Market for Pain Medication. Bradford WD; Kleit AN Health Econ; 2015 Jul; 24(7):859-75. PubMed ID: 25059655 [TBL] [Abstract][Full Text] [Related]
42. Direct-to-consumer advertising of prescription drugs. Frosch DL; Grande D LDI Issue Brief; 2010; 15(3):1-4. PubMed ID: 20469541 [TBL] [Abstract][Full Text] [Related]
43. Physicians Treating Alzheimer's Disease Patients Should Be Aware that Televised Direct-to-Consumer Advertising Links More Strongly to Drug Utilization in Older Patients. Feldman R J Alzheimers Dis; 2021; 81(3):1169-1179. PubMed ID: 33843688 [TBL] [Abstract][Full Text] [Related]
44. Update on "Cell Therapy" Clinics Offering Treatments of Ocular Conditions Using Direct-To-Consumer Marketing Websites in the U.S. Kalavar M; Lovett EA; Nicholas MP; Ross-Hirsch A; Nirwan RS; Sridhar J; Patel S; Flynn HW; Albini TA; Kuriyan AE Am J Ophthalmol; 2024 Nov; 267():135-141. PubMed ID: 38880376 [TBL] [Abstract][Full Text] [Related]
45. Pharmaceutical companies and their drugs on social media: a content analysis of drug information on popular social media sites. Tyrawski J; DeAndrea DC J Med Internet Res; 2015 Jun; 17(6):e130. PubMed ID: 26032738 [TBL] [Abstract][Full Text] [Related]
46. Individual- and Ad-Level Predictors of Perceptions of Serious and Actionable Risks in Direct-to-Consumer Prescription Drug TV Advertising. Aikin KJ; Boudewyns V; Betts KR; Southwell BG; Williams P J Health Commun; 2019; 24(5):536-546. PubMed ID: 31253071 [TBL] [Abstract][Full Text] [Related]
47. Complaints addressed by regulatory authorities in drug advertising targeted at consumers: Cases across three, different countries. Song SY; Lee JH; Kim SC; Choi JW; Bae J; Kim E Res Social Adm Pharm; 2019 Oct; 15(10):1274-1279. PubMed ID: 30552049 [TBL] [Abstract][Full Text] [Related]
48. Promotion and marketing of bioidentical hormone therapy on the internet: a content analysis of websites. Yuksel N; Treseng L; Malik B; Ogbogu U Menopause; 2017 Oct; 24(10):1129-1135. PubMed ID: 28609391 [TBL] [Abstract][Full Text] [Related]
49. Disease-specific direct-to-consumer advertising for reminding consumers to take medications. Bhutada NS; Rollins BL J Am Pharm Assoc (2003); 2015; 55(4):434-7. PubMed ID: 26161486 [TBL] [Abstract][Full Text] [Related]
50. Linking the content to demographic reach of online advertising of electronic nicotine delivery systems. Timberlake DS; Nikitin D; Garcia-Cano J; Cino S; Savkina M; Pechmann C Tob Control; 2018 Jul; 27(4):463-469. PubMed ID: 28634162 [TBL] [Abstract][Full Text] [Related]
51. Direct-to-consumer advertising skepticism and the use and perceived usefulness of prescription drug information sources. DeLorme DE; Huh J; Reid LN Health Mark Q; 2009; 26(4):293-314. PubMed ID: 19916096 [TBL] [Abstract][Full Text] [Related]
52. Association of Attorney Advertising and FDA Action with Prescription Claims: A Time Series Segmented Regression Analysis. Tippett EC; Chen BK Drug Saf; 2015 Dec; 38(12):1169-78. PubMed ID: 26384489 [TBL] [Abstract][Full Text] [Related]
53. Can direct-to-consumer advertising of prescription drugs be effectively regulated? Lexchin J; Menkes DB N Z Med J; 2019 Jun; 132(1496):59-65. PubMed ID: 31170134 [TBL] [Abstract][Full Text] [Related]
54. An Updated Analysis of Direct-to-Consumer Television Advertisements for Prescription Drugs. Applequist J; Ball JG Ann Fam Med; 2018 May; 16(3):211-216. PubMed ID: 29760024 [TBL] [Abstract][Full Text] [Related]
55. Trends in internet search activity, media coverage, and patient-centered health information after the FDA safety communications on surgical mesh for pelvic organ prolapse. Stone BV; Forde JC; Levit VB; Lee RK; Te AE; Chughtai B Int Urogynecol J; 2016 Nov; 27(11):1761-1766. PubMed ID: 27209310 [TBL] [Abstract][Full Text] [Related]
56. FDA direct-to-consumer advertising for prescription drugs: what are consumer preferences and response tendencies? Khanfar N; Loudon D; Sircar-Ramsewak F Health Mark Q; 2007; 24(1-2):77-91. PubMed ID: 19042521 [TBL] [Abstract][Full Text] [Related]
57. Trust in prescription drug brand websites: website trust cues, attitude toward the website, and behavioral intentions. Huh J; Shin W J Health Commun; 2014; 19(2):170-91. PubMed ID: 24094133 [TBL] [Abstract][Full Text] [Related]
58. Consumers' Understanding of FDA Approval Requirements and Composite Scores in Direct-to-Consumer Prescription Drug Print Ads. O'Donoghue AC; Sullivan HW; Williams PA; Squire C; Betts KR; Fitts Willoughby J; Parvanta S J Health Commun; 2016 Aug; 21(8):927-34. PubMed ID: 27414000 [TBL] [Abstract][Full Text] [Related]
59. Assessing "Cell Therapy" Clinics Offering Treatments of Ocular Conditions using Direct-to-Consumer Marketing Websites in the United States. Nirwan RS; Albini TA; Sridhar J; Flynn HW; Kuriyan AE Ophthalmology; 2019 Oct; 126(10):1350-1355. PubMed ID: 30904542 [TBL] [Abstract][Full Text] [Related]
60. The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare? Morgan S; Mintzes B; Barer M J Health Serv Res Policy; 2003 Oct; 8(4):237-44. PubMed ID: 14596759 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]